Compass Pathways Inc News Today

Transcranial magnetic stimulation is associated with reductions in both anxiety and depression scores in patients with both disorders, a large new analysis shows.

The ALPS Medical Breakthroughs ETF (SBIO) rallied 14.53% last week, propelled by positive earnings and two significant M&A announcements in the portfolio. 

This Could Be One of the Best Ways to Treat Mental Health Issues for Millions Over the last 20 years, “The number of psychopharmacological drugs research programs in larger drug firms has shrunk by 70% in the past decade,” reported The Guardian. “In general the larger companies have walked away from psychiatry. There are a few companies who have maintained efforts in the area but 70% tells you it’s been a pretty remarkable departure. Many withdrew from neuroscience entirely.” ...

Psychedelics Could be Your Next Multi-Billion-Dollar Opportunity It may only be a matter of time before mind-altering drugs make their way into Big Pharma treatments for mental health issues, such as depression, anxiety, obsessive compulsive disorder, trauma, and addiction. If that happens, the industry could be worth well over $100 billion, as noted by analyst at Eight Capital, benefiting companies such as Silo Wellness (CSE:SINO), Compass Pathways Inc. (NASDAQ:CMPS), HAVN Life Scie...

Psilocybin Could be a Major Game Changer for Millions of People The psychedelics story is quickly gaining momentum. Over the last few months, Denver, Oakland, and Santa Cruz have recently legalized its use. Joining them, Ann Arbor, Michigan lawmakers voted to decriminalize psilocybin mushrooms, as well. Now, even Florida could soon legalize magic mushrooms by 2022. In fact, according to Miami New Times, “A recent bill introduced by Florida House Rep. Michael Grieco aims to legaliz...